| Name | Title | Contact Details |
|---|---|---|
Vivian Montijo |
Associate Director Supply Chain | Profile |
Nelson Costa |
Associate Director of Marketing - Headache KOL Lead | Profile |
Soumen Pattanayek |
Sr. Director Research & Development | Profile |
Darrell Baranowski |
Director, R&D Project Leadership and Strategy | Profile |
Suparna Mukherjee |
Director clinical R&D | Profile |
SENN CHEMICALS is a San Diego, CA-based company in the Healthcare, Pharmaceuticals, & Biotech sector.
We design and manufacture functional and sustainable applications for human and veterinary immobilization and mobility.
Revive is a life sciences company focused on the research and development of therapeutics for infectious diseases and rare disorders, and it is prioritizing drug development efforts to take advantage of several regulatory incentives awarded by the FDA such as Orphan Drug, Fast Track, Breakthrough Therapy and Rare Pediatric Disease designations.
La Jolla Pharmaceutical Company is a biopharmaceutical company focused on the discovery, development and commercialization of innovative therapies intended to significantly improve outcomes in patients suffering from life-threatening diseases. The Company has several product candidates in development. LJPC-501 is La Jolla`s proprietary formulation of angiotensin II for the potential treatment of catecholamine-resistant hypotension. LJPC-401 is La Jolla`s novel formulation of hepcidin for the potential treatment of conditions characterized by iron overload, such as hereditary hemochromatosis, beta thalassemia, sickle cell disease and myelodysplastic syndrome. LJPC-30S is our next-generation gentamicin derivative program that is focused on therapeutics for the potential treatment of serious bacterial infections as well as rare genetic disorders, such as cystic fibrosis and Duchenne muscular dystrophy.